María Teresa Soler-Monsó

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

Zuzana Kos, Elvire Roblin, Rim S. Kim et al. · npj Breast Cancer · 2020 · 206 citations · Full text

Medicine, Oncology, Pathology +16

Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population

Jorge Gómez‐Miragaya, Marta Palafox, Laia Paré et al. · Stem Cell Reports · 2017 · 71 citations · Full text

Medicine, Oncology, Pharmacology +17

Modification of BRCA1-associated breast cancer risk by HMMR overexpression

Francesca Mateo, Zhengcheng He, Lin Mei et al. · Nature Communications · 2022 · 53 citations · Full text

Medicine, Genetics, Oncology +17

RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer

Adrián Sanz‐Moreno, Sònia Palomeras, Kim Pedersen et al. · Breast Cancer Research · 2021 · 30 citations · Full text

Medicine, Cancer Biology, Oncology +16

Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial)

Amparo García‐Tejedor, Carlos Ortega-Expósito, Sira Salinas et al. · Frontiers in Oncology · 2023 · 26 citations · Full text

Medicine, Oncology, Surgery +17